These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 28034080
21. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M. Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790 [Abstract] [Full Text] [Related]
22. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ. Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025 [Abstract] [Full Text] [Related]
23. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma]. Balwierz W, Pietrys D, Romanowska-Dixon B, Kobylarz J, Pawińska-Wasikowska K, Moryl-Bujakowska A. Przegl Lek; 2010 Nov; 67(6):404-8. PubMed ID: 21344770 [Abstract] [Full Text] [Related]
24. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
25. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma]. Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A. Med Wieku Rozwoj; 2001 Mar; 5(3 Suppl 1):15-23. PubMed ID: 12004148 [Abstract] [Full Text] [Related]
29. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, Lee TC, Murphree AL. Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170 [Abstract] [Full Text] [Related]
30. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina. Chantada GL, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P, Manzitti J. Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706 [Abstract] [Full Text] [Related]
31. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH. Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458 [Abstract] [Full Text] [Related]
32. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. Fabian ID, Stacey AW, Johnson KP, Onadim Z, Chowdhury T, Duncan C, Reddy MA, Sagoo MS. Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263 [Abstract] [Full Text] [Related]
33. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Abramson DH, Fabius AW, Francis JH, Marr BP, Dunkel IJ, Brodie SE, Escuder A, Gobin YP. Ophthalmic Genet; 2017 Jan; 38(1):16-21. PubMed ID: 28095092 [Abstract] [Full Text] [Related]
38. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M. J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500 [Abstract] [Full Text] [Related]